110 related articles for article (PubMed ID: 7968791)
1. Recurrent venous thrombosis as the presenting manifestation of acute lymphocytic leukemia: leukemic cell procoagulant activity is not responsible for the hypercoagulable state.
Bilgrami S; Greenberg BR; Weinstein RE; Hair GA; Rickles FR
Med Pediatr Oncol; 1995 Jan; 24(1):40-5. PubMed ID: 7968791
[TBL] [Abstract][Full Text] [Related]
2. [Activity of procoagulant and fibrinolysis in homogenate of leukemic cells].
Wada H; Tanigawa M; Suzuki H; Takagi M; Mori Y; Ohno T; Kita K; Kobayashi T; Deguchi K; Shirakawa S
Rinsho Ketsueki; 1989 Oct; 30(10):1783-7. PubMed ID: 2593244
[TBL] [Abstract][Full Text] [Related]
3. Coagulant and fibrinolytic activities in the leukemic cell lysates.
Wada H; Nagano T; Tomeoku M; Kuto M; Karitani Y; Deguchi K; Shirakawa S
Thromb Res; 1983 May; 30(4):315-22. PubMed ID: 6351339
[TBL] [Abstract][Full Text] [Related]
4. Effect of all-trans retinoic acid and arsenic trioxide on tissue factor expression in acute promyelocytic leukemia cells.
Guo W; Wang H; Zhao W; Zhu J; Ju B; Wang X
Chin Med J (Engl); 2001 Jan; 114(1):30-4. PubMed ID: 11779431
[TBL] [Abstract][Full Text] [Related]
5. Microparticle bearing tissue factor: a link between promyelocytic cells and hypercoagulable state.
Gheldof D; Mullier F; Bailly N; Devalet B; Dogné JM; Chatelain B; Chatelain C
Thromb Res; 2014 Mar; 133(3):433-9. PubMed ID: 24290525
[TBL] [Abstract][Full Text] [Related]
6. [Effects of realgar on tissue factor expression of NB4 and MR2 cells].
Zhao XA; Liu SX
Zhongguo Zhong Yao Za Zhi; 2003 Jun; 28(6):553-6. PubMed ID: 15015339
[TBL] [Abstract][Full Text] [Related]
7. [Effects of all-trans retinoic acid and arsenic trioxide on tissue factor expression of acute promyelocytic leukemia cells].
Guo W; Wang H; Zhao W
Zhonghua Yi Xue Za Zhi; 2000 May; 80(5):327-31. PubMed ID: 11798779
[TBL] [Abstract][Full Text] [Related]
8. Tissue factor expression in human leukemic cells.
Hair GA; Padula S; Zeff R; Schmeizl M; Contrino J; Kreutzer DL; de Moerloose P; Boyd AW; Stanley I; Burgess AW; Rickles FR
Leuk Res; 1996 Jan; 20(1):1-11. PubMed ID: 8632672
[TBL] [Abstract][Full Text] [Related]
9. Elevated tissue factor levels in leukemic cell homogenate.
Nakasaki T; Wada H; Watanabe R; Mori Y; Gabazza EC; Kageyama S; Nishikawa M; Shiku H
Clin Appl Thromb Hemost; 2000 Jan; 6(1):14-7. PubMed ID: 10726043
[TBL] [Abstract][Full Text] [Related]
10. All trans-retinoic acid modulates the procoagulant activity of human breast cancer cells.
Marchetti M; Russo L; Balducci D; Falanga A
Thromb Res; 2011 Oct; 128(4):368-74. PubMed ID: 21458031
[TBL] [Abstract][Full Text] [Related]
11. New insights into the pathogenesis of coagulation dysfunction in acute promyelocytic leukemia.
Tallman MS; Hakimian D; Kwaan HC; Rickles FR
Leuk Lymphoma; 1993 Sep; 11(1-2):27-36. PubMed ID: 8220153
[TBL] [Abstract][Full Text] [Related]
12. Cancer procoagulant in acute non lymphoid leukemia: relationship of enzyme detection to disease activity.
Donati MB; Falanga A; Consonni R; Alessio MG; Bassan R; Buelli M; Borin L; Catani L; Pogliani E; Gugliotta L
Thromb Haemost; 1990 Aug; 64(1):11-6. PubMed ID: 2274915
[TBL] [Abstract][Full Text] [Related]
13. Acute promyelocytic leukemia presenting as sudden blindness and sinus vein thrombosis.
Hazani A; Weidenfeld Y; Tatarsky I; Bental E
Am J Hematol; 1988 May; 28(1):56-7. PubMed ID: 3163466
[TBL] [Abstract][Full Text] [Related]
14. Cancer and thrombosis: from Phlegmasia alba dolens to transgenic mice.
Donati MB
Thromb Haemost; 1995 Jul; 74(1):278-81. PubMed ID: 8578472
[TBL] [Abstract][Full Text] [Related]
15. Elevated levels of leukocyte tissue factor mRNA in patients with venous thromboembolism.
Kamikura Y; Wada H; Nobori T; Kobayashi T; Sase T; Nishikawa M; Ishikura K; Yamada N; Abe Y; Nishioka J; Nakano T; Shiku H
Thromb Res; 2005; 116(4):307-12. PubMed ID: 16038715
[TBL] [Abstract][Full Text] [Related]
16. Hemostatic abnormalities associated with acute promyelocytic leukemia and corrective effects of all-trans-retinoic acid or arsenic trioxide treatment.
Zhao W; Wang X; Guo W; Qu B; Wang H; Shen Z; Chen Z; Wang Z
Chin Med J (Engl); 2000 Mar; 113(3):236-40. PubMed ID: 11775254
[TBL] [Abstract][Full Text] [Related]
17. The prothrombotic state in cancer: pathogenic mechanisms.
De Cicco M
Crit Rev Oncol Hematol; 2004 Jun; 50(3):187-96. PubMed ID: 15182825
[TBL] [Abstract][Full Text] [Related]
18. Procoagulant factors in patients with cancer.
Molnar S; Guglielmone H; Lavarda M; Rizzi ML; Jarchum G
Hematology; 2007 Dec; 12(6):555-9. PubMed ID: 17852460
[TBL] [Abstract][Full Text] [Related]
19. Procoagulant activity of extracellular vesicles as a potential biomarker for risk of thrombosis and DIC in patients with acute leukaemia.
Gheldof D; Haguet H; Dogné JM; Bouvy C; Graux C; George F; Sonet A; Chatelain C; Chatelain B; Mullier F
J Thromb Thrombolysis; 2017 Feb; 43(2):224-232. PubMed ID: 28074413
[TBL] [Abstract][Full Text] [Related]
20. Cancer procoagulant in acute lymphoblastic leukemia.
Alessio MG; Falanga A; Consonni R; Bassan R; Minetti B; Donati MB; Barbui T
Eur J Haematol; 1990 Aug; 45(2):78-81. PubMed ID: 2209822
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]